Lobbyist Public Search

Records prior to registration year 2005 are not available online. Contact the Lobbyist Division here for assistance.	Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
	Your comments are welcome: submit feedback

Disclosure reporting details

Back to search detail summary

Lobbyist disclosure reporting period: 01/01/2018 - 06/30/2018

Lobbyist name	Leslie Wood
Business name	Pharmaceutical Research and Manufacturers of America, Inc.
Address	950 F Street, NW Suite 300
City, state, zip code	Washington, DC 20004
Country	US
Agent type	Both
Phone	202-835-3451

Operating Expenses

No operating expenses were filed for this disclosure reporting period.

Activities, Bill Numbers and Titles

Client: Pharmaceutical Research and Manufacturers of America, Inc.

House / Senate	Bill Number or Agency Name	Bill title or activity	Agent position	Amount	Direct business association
Senate Bill	2211	An Act furthering health empowerment and affordability by leveraging transformative health care.	Oppose	$2,482.00	N/A
House Bill	3947	An Act providing for dementia-specific training for certain employees of long-term care facilities.	Neutral	$992.80	N/A
Executive		Massachusetts Senate Budget Outside Sections 22 and 58. Activity included discussions with employees of the Legislature.	Oppose	$2,482.00	N/A
Senate Bill	2202	An Act furthering health empowerment and affordability by leveraging transformative health care.	Oppose	$2,482.00	N/A
House Bill	4639	An Act establishing the Honorable Peter V. Kocot Act to enhance access to high quality, affordable and transparent healthcare in the Commonwealth	Neutral	$7,446.00	N/A
House Bill	4056	An Act relative to substance use, treatment, education and prevention	Neutral	$992.80	N/A
Executive		Opposed the Executive Office of Health and Human Services’ 1115 waiver amendment creating a closed formulary for pharmaceuticals. Activity included discussions with employees of the Executive Office of Health and Human Services.	Oppose	$12,410.00	N/A
			Total amount	$29,287.60

Meals, Travel, and Entertainment Expenses

No meals, travel, or entertainment expenses were filed for this disclosure reporting period.

Additional Expenses

No additional expenses were filed for this disclosure reporting period.

Campaign Contributions

No campaign contributions were filed for this disclosure reporting period.